Skip to main content


Page 4 of 6

  1. The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace the mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP mea...

    Authors: Hae-Young Lee, Jinho Shin, Gheun-Ho Kim, Sungha Park, Sang-Hyun Ihm, Hyun Chang Kim, Kwang-il Kim, Ju Han Kim, Jang Hoon Lee, Jong-Moo Park, Wook Bum Pyun and Shung Chull Chae
    Citation: Clinical Hypertension 2019 25:20
  2. Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients’ characteristics. Additionally, the target b...

    Authors: Kwang-il Kim, Sang-Hyun Ihm, Gheun-Ho Kim, Hyeon Chang Kim, Ju Han Kim, Hae-Young Lee, Jang Hoon Lee, Jong-Moo Park, Sungha Park, Wook Bum Pyun, Jinho Shin and Shung Chull Chae
    Citation: Clinical Hypertension 2019 25:19
  3. Preeclampsia is leading causes of maternal and perinatal morbidity and mortality worldwide and it is a hypertensive disorder which usually occurs after 20 weeks of gestation. In Ethiopia, according to Ethiopia...

    Authors: Alemayehu Sayih Belay and Tofik Wudad
    Citation: Clinical Hypertension 2019 25:14
  4. The dysregulation of histone deacetylase (HDAC) protein expression or its enzyme activity is implicated in a variety of diseases. Cardiac HDAC6 and HDAC8 enzyme activity induced by deoxycorticosterone acetate ...

    Authors: Hae Jin Kee, Yuhee Ryu, Young Mi Seok, Sin Young Choi, Simei Sun, Gwi Ran Kim and Myung Ho Jeong
    Citation: Clinical Hypertension 2019 25:13
  5. Previous studies demonstrated that visit-to-visit variability of blood pressure (BP) has significant relationship with cardiovascular disease. Visit-to-visit variability in BP might have prognostic value for c...

    Authors: Hyung Tak Lee, June Namgung, Young-Hyo Lim, Hwan-Cheol Park, Jin-Kyu Park and Jinho Shin
    Citation: Clinical Hypertension 2019 25:11
  6. Neonatal hypertension is defined as persistent systolic and/or diastolic blood pressures above the 95th percentile compared to other infants of similar gestational age and size. Neonatal hypertension is a rare...

    Authors: Jena Deitrick, Kayle Stevenson, Daniel Nguyen, William Sessions, Vijay Linga and Tetyana Vasylyeva
    Citation: Clinical Hypertension 2019 25:10
  7. Hypertension is the major risk factor for cardiovascular diseases and prevalence rates are critical to understanding the burden and envisaging health service requirements and resource allocation. We aimed to p...

    Authors: Njideka U. Okubadejo, Obianuju B. Ozoh, Oluwadamilola O. Ojo, Ayesha O. Akinkugbe, Ifedayo A. Odeniyi, Oluseyi Adegoke, Babawale T. Bello and Osigwe P. Agabi
    Citation: Clinical Hypertension 2019 25:7
  8. Every third patient in the clinic is misdiagnosed due to white-coat phenomenon, necessitating needless and costly treatment. We aimed to study the hemodynamic response of the physician’s visit on hypertensive ...

    Authors: Hunaina Shahab, Hamza Sohail Khan, Aysha Almas, Sohail Abrar Khan, Azmina Artani and Aamir Hameed Khan
    Citation: Clinical Hypertension 2019 25:8
  9. Restriction of dietary salt is widely recommended in the management of hypertension, but assessment of individual salt intake has drawn little attention. Monitoring nutritional salt intake through sodium excre...

    Authors: Yasmin Jahan, Michiko Moriyama, Md Moshiur Rahman and Atiqur Rahman
    Citation: Clinical Hypertension 2019 25:3
  10. Angina pectoris with a normal coronary angiogram, termed microvascular angina (MVA), is an important clinical entity; however, its causes remain unclear. Autonomic dysfunction is one of the possible causes. Th...

    Authors: Bong-Joon Kim, Eun-Ah Jo, Sung-Il Im, Hyun-Su Kim, Jung Ho Heo and Kyoung-Im Cho
    Citation: Clinical Hypertension 2019 25:4
  11. BMI is an indicator commonly used in the world to measure the weight and height of the body, it reflects the comprehensive outcome of acquired lifestyle; FH is a sign reflecting the main role of genetic factor...

    Authors: An-le Li, Qian Peng, Yue-qin Shao, Xiang Fang and Yi-ying Zhang
    Citation: Clinical Hypertension 2019 25:6
  12. The current gold standard for the diagnosis of white-coat effect is by the 24-h ambulatory blood pressure monitoring (ABPM) which may not be readily available in every primary care setting. Previous studies ha...

    Authors: Kam Sum Chan, Kit Ping Loretta Lai, Pang Fai Chan, Man Hei Matthew Luk and Vai Kiong David Chao
    Citation: Clinical Hypertension 2019 25:2
  13. A considerable proportion of cardiovascular events could be attributed to poor adherence to antihypertensive medications. Adverse effects can be severe enough to affect adherence to antihypertensive medication...

    Authors: Eyob Alemayehu Gebreyohannes, Akshaya Srikanth Bhagavathula, Tamrat Befekadu Abebe, Yonas Getaye Tefera and Tadesse Melaku Abegaz
    Citation: Clinical Hypertension 2019 25:1
  14. In the original publication of this article [1], the reference number [42] under the section ‘vitamin D and Cardiovascular diseases’ (page no.2) should be [37].

    Authors: Babikir Kheiri, Ahmed Abdalla, Mohammed Osman, Sahar Ahmed, Mustafa Hassan and Ghassan Bachuwa
    Citation: Clinical Hypertension 2018 24:19

    The original article was published in Clinical Hypertension 2018 24:9

  15. Measures of the functional and structural properties of blood vessels can be used to assess preclinical stage of vascular disorders. Recent experimental and population studies show that arterial stiffening pre...

    Authors: Young S. Oh
    Citation: Clinical Hypertension 2018 24:17
  16. Hypokalemia in the presence of hypertension is often attributed to primary hyperaldosteronism as a cause of secondary hypertension, however secondary hyperaldosteronism may present similarly. Accessory renal a...

    Authors: Pei Lin Chan and Florence Hui Sieng Tan
    Citation: Clinical Hypertension 2018 24:15
  17. It has been long debated whether menopause itself is a risk factor for hypertension in peri-menopausal women. We aimed to assess the association between menopause and hypertension, and whether metabolic syndro...

    Authors: Gyu Chul Oh, Kee Soo Kang, Chan Soon Park, Ho Kyung Sung, Kyoung Hwa Ha, Hyeon Chang Kim, Sungha Park, Sang Hyun Ihm and Hae-Young Lee
    Citation: Clinical Hypertension 2018 24:14
  18. The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea.

    Authors: Hyeon Chang Kim and Myeong-Chan Cho
    Citation: Clinical Hypertension 2018 24:13
  19. Preeclampsia (PE) is a serious maternal complication during pregnancy. Associated arterial stiffness in PE patients leads to increased risks of cardiovascular diseases later in life. Cholesterol efflux capacit...

    Authors: Shutan Liao, Hao Wu and Ruiying Chen
    Citation: Clinical Hypertension 2018 24:11
  20. Fimasartan (Kanarb; Boryung Pharmaceutical Co., Ltd., Seoul, Republic of Korea) is a non-protein angiotensin II receptor blocker that selectively blocks the AT1 receptor. No prior large-scale study has investi...

    Authors: Dong Joo Oh, Su-Eun Han, Seung Hee Jeong, Myung Sook Hong and Seong Choon Choe
    Citation: Clinical Hypertension 2018 24:10
  21. Data are limited with regard to the relationship of albuminuria and major adverse cardiovascular events (MACE) in Chinese elder patients with high cardiovascular risk.

    Authors: Mingming Liu, Yan Liang, Jun Zhu, Yanmin Yang, Wenfang Ma and Guozheng Zhang
    Citation: Clinical Hypertension 2018 24:12
  22. Vitamin D, a fat-soluble prohormone, has wide-ranging roles in the regulation of many physiological processes through their interactions with the vitamin D receptors (VDR). It plays a major role in bones and c...

    Authors: Babikir Kheiri, Ahmed Abdalla, Mohammed Osman, Sahar Ahmed, Mustafa Hassan and Ghassan Bachuwa
    Citation: Clinical Hypertension 2018 24:9

    The Correction to this article has been published in Clinical Hypertension 2018 24:19

  23. Several diseases, such as obesity, hypertension and type 2 diabetes are frequently associated with metabolic abnormalities, high costs of healthcare and morbi-mortality; thus the aim of this study was to inves...

    Authors: Bruna M. Giglio, Renata C. Fernandes, Ana B. Marini, João F. Mota and Gustavo D. Pimentel
    Citation: Clinical Hypertension 2018 24:8
  24. The data on the association of sleep duration and blood pressure in the pediatric age group have been mixed and most studies have focused on weekday sleep duration. The purpose of this study was to compare the...

    Authors: Neena Gupta, Louise Maranda and Rakesh Gupta
    Citation: Clinical Hypertension 2018 24:7
  25. Hypertension is the second most common cause of chronic kidney disease (CKD). Therefore, the aims of the study were to assess the knowledge, attitudes and practices (KAP) of hypertensive patients towards preve...

    Authors: Hala H. Sa’adeh, Razan N. Darwazeh, Amani A. Khalil and Sa’ed H. Zyoud
    Citation: Clinical Hypertension 2018 24:6
  26. Recent studies suggest an association between cytomegalovirus (CMV) infection and hypertension. In the present study, we used a variety of antigens and different assay methods to investigate the relationship b...

    Authors: Jong-Chan Youn, Jun Yong Kim, Min Kyung Jung, Hee Tae Yu, Su-Hyung Park, In-Cheol Kim, Sun Ki Lee, Suk-Won Choi, Seongwoo Han, Kyu-Hyung Ryu, Sungha Park and Eui-Cheol Shin
    Citation: Clinical Hypertension 2018 24:5
  27. A seemingly interesting observation in patients with sickle cell anaemia (SCA) is that they usually have lower systemic blood pressures (BP) and insulin resistance than persons in the general population in spi...

    Authors: Lawrence A. Olatunji, Olatunde P. Olabode, Olawale M. Akinlade, Abiola S. Babatunde, Victoria A. Olatunji and Ayodele O. Soladoye
    Citation: Clinical Hypertension 2018 24:3
  28. Few data is available on the association between body mass index (BMI), serum uric acid (SUA) levels and blood pressure (BP) categories in the disease continuum, when efforts for its prevention may be applicable.

    Authors: Ryuichi Kawamoto, Daisuke Ninomiya, Kensuke Senzaki and Teru Kumagi
    Citation: Clinical Hypertension 2018 24:1
  29. Hypertension is the major contributor to cardiovascular diseases related morbidity and mortality. Blood pressure is not well controlled in the majority of patients with both diabetes and hypertension. The main...

    Authors: Sintayehu Muleta, Tsegaye Melaku, Legese Chelkeba and Desta Assefa
    Citation: Clinical Hypertension 2017 23:29
  30. The use of impedance cardiography (ICG) may play a role in the assessment of cardiac effects of hypertension (HT), especially its hemodynamic features. Hypertensive heart disease involves structural changes an...

    Authors: Rodrigo Nazário Leão, Pedro Marques Silva, Luísa Branco, Helena Fonseca, Bruno Bento, Marta Alves, Daniel Virella and Roberto Palma Reis
    Citation: Clinical Hypertension 2017 23:28
  31. Autonomic nervous system activity has been shown to be altered in patients with vasospastic angina (VA). Heart rate recovery (HRR) is a simple, non-invasive measurement of autonomic nervous system dysfunction....

    Authors: Hyunsu Kim, Sang-Hoon Cho, Kyoung-Im Cho, Bong-Joon Kim, Sung-Il Im and Jung-Ho Heo
    Citation: Clinical Hypertension 2017 23:24
  32. We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic paramet...

    Authors: Venu Gopal Jonnalagadda, Kanchan Choudhary and Vijay Kranti Matety
    Citation: Clinical Hypertension 2017 23:27
  33. The purpose of this survey was to evaluate the performance of hypertension screening in medical institutions conducting the national general health screening program of the Republic of Korea.

    Authors: Seung Won Lee, Hae-Young Lee, Sang Hyun Ihm, Sung Ha Park, Tae Hyun Kim and Hyeon Chang Kim
    Citation: Clinical Hypertension 2017 23:23
  34. Hypertension is one of the leading causes of disability and death in both developed and developing countries that need urgent strategies to implement interventions that control it. Appropriate lifestyle change...

    Authors: Eyasu Siyum Buda, Lolemo Kelbiso Hanfore, Robera Olana Fite and Alula Seyum Buda
    Citation: Clinical Hypertension 2017 23:26
  35. Carvedilol is used in the management of hypertension, ischemic heart disease, heart failure and most recently, portal hypertension. It has been associated with improved outcomes regarding variceal bleeding, he...

    Authors: Satish Maharaj, Karan Seegobin, Julio Perez-Downes, Belinda Bajric, Simone Chang and Pramod Reddy
    Citation: Clinical Hypertension 2017 23:25
  36. The salt-taste threshold can influence the salt appetite, and is thought to be another marker of sodium intake. Many studies have mentioned the relationship between the sodium intake and blood pressure (BP). T...

    Authors: Chang-Yeon Kim, Mi-Kyung Ye and Young Soo Lee
    Citation: Clinical Hypertension 2017 23:22
  37. Arterial stiffness increases pressure load to the left ventricle (LV), leading to LV hypertrophy and subendocardial ischemia. Neurohormones stimulate myocardial fibrosis and LV dysfunction. We aimed to explore...

    Authors: Darae Kim, Chi Young Shim, Geu-Ru Hong, Sungha Park, InJeong Cho, Hyuk-Jae Chang, Jong-Won Ha and Namsik Chung
    Citation: Clinical Hypertension 2017 23:21
  38. Hypertension is a risk factor for coronary heart disease and stroke, and is one of the leading causes of death. Although over a billion people are affected worldwide, only half of them receive adequate treatme...

    Authors: Gyu Chul Oh, Hae-Young Lee, Wook Jin Chung, Ho-Joong Youn, Eun-Joo Cho, Ki-Chul Sung, Shung Chull Chae, Byung-Su Yoo, Chang Gyu Park, Soon Jun Hong, Young Kwon Kim, Taek-Jong Hong, Dong-Ju Choi, Min Su Hyun, Jong Won Ha, Young Jo Kim…
    Citation: Clinical Hypertension 2017 23:18
  39. Flow Mediated Dilation (FMD) has immense potential to become a clinical, non-invasive biomarker of endothelial function and nitric oxide bioavailability, which regulate vasomotor activity. Unfortunately, FMD a...

    Authors: Brycen Ratcliffe, Robert Pawlak, Francisco Morales, Caleb Harrison and Alvaro N. Gurovich
    Citation: Clinical Hypertension 2017 23:17
  40. The Korean Registry of Target Organ Damage in Hypertension aims to evaluate the clinical characteristics and prevalence of subclinical target organ damage in Korean hypertensive patients.

    Authors: Suk-Won Choi, Seong Woo Han, Jong Sun Ok, Byung-Su Yoo, Mi-Seung Shin, Sung Ha Park and Kyu-Hyung Ryu
    Citation: Clinical Hypertension 2017 23:16
  41. It has been reported that deep breathing could reduce blood pressures (BP) in general. It is also known that BP is decreased during inhalation and increased during exhalation. Therefore, the measured BPs could...

    Authors: Natalia Herakova, Nnenna Harmony Nzeribe Nwobodo, Ying Wang, Fei Chen and Dingchang Zheng
    Citation: Clinical Hypertension 2017 23:15
  42. Clients on anti-retroviral therapy (ART) are living longer and have risk of hypertension. Side effects of medicines and aging increase this risk. Hypertension prevalence among clients on ART in Kadoma City was...

    Authors: Pamela Nyaradzai Magande, Daniel Chirundu, Notion Tafara Gombe, More Mungati and Mufuta Tshimanga
    Citation: Clinical Hypertension 2017 23:14

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.756 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    136 days submission to accept (Median)

    2023 Usage 
    59 Altmetric mentions